Rosalind Advisors, Inc. Portfolio

Auto-discovered active 13F filer.

SEC 13F CIK: 0001622627

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltHigh Turnover how tags are computed

Q4 2024 · 36 positions · Total reported value $194.74M · Top-10 concentration 66.0% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 54.8% · 9 new · 11 cut · 3 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): +4.7% · vs SPY +2.5% · Prev Value $269.06M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -5.8% · vs SPY -7.9% · Latest Value $244.66M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q4 2024 13F filing, Rosalind Advisors, Inc. disclosed 36 equity positions with a combined reported value of $194.74M. The filing implies a focused portfolio: its ten largest positions account for 66.0% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q4 2024 were DCTH ($31.91M), MYO ($19.31M), MDWD ($11.18M). By sector, the heaviest allocations are Health Care 83.2%, Materials 0.8%. Versus the prior quarter, allocation shifted toward Health Care (+3.8pp), Materials (+0.8pp) and away from Industrials (-0.7pp), Other (-3.9pp).

Versus the prior quarter, Rosalind Advisors, Inc. opened 9 new positions, trimmed 11 and fully exited 3, a turnover rate of 54.8% of positions. The portfolio's overlap with the prior quarter was 45% of names.

The largest new positions opened in Q4 2024 were CMRX ($10.61M), URGN ($9.27M), SVRA ($8.15M).

Of the 3 positions fully exited versus the prior quarter, the largest were CYBN ($9.56M), CLRB ($7.86M), OTLK ($2.40M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2024)

  • CMRX CHIMERIX INC · $10.61M
  • URGN UROGEN PHARMA LTD · $9.27M
  • SVRA SAVARA INC · $8.15M
  • FENC FENNEC PHARMACEUTICALS INC · $7.96M
  • HELP CYBIN INC · $7.15M
  • VSTM VERASTEM INC · $4.65M
  • REPL REPLIMUNE GROUP INC · $3.15M
  • BMEA BIOMEA FUSION INC · $2.76M

Fully Exited (vs previous quarter)

  • CYBN CYBIN INC · prev qtr: $9.56M
  • CLRB CELLECTAR BIOSCIENCES INC · prev qtr: $7.86M
  • OTLK OUTLOOK THERAPEUTICS INC · prev qtr: $2.40M
  • VERU VERU INC · prev qtr: $2.07M
  • ABVX ABIVAX SA · prev qtr: $1.61M · history
  • FBIO FORTRESS BIOTECH INC · prev qtr: $726.59K
  • DERM JOURNEY MED CORP · prev qtr: $598.43K
  • NAMS NEWAMSTERDAM PHARMA COMPANY · prev qtr: $168.04K

Insider Transactions (Form 4)

Latest Rosalind Advisors, Inc. buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-10-13 J DELCATH SYSTEMS, INC. 27,502 — SEC filing
2026-10-13 Conversion DELCATH SYSTEMS, INC. 3,627 — SEC filing

All insider transactions →

Fund Profile

Rosalind Advisors, Inc. is an SEC-registered 13F filer. As of Q2 2026 it reported 33 US equity positions with a combined value of $269.06M. HoldingsHub carries 11 quarters of its filings (Q4 2023–Q2 2026).

Portfolio Structure

  • 33 positions · $269.06M reported value (Q2 2026)
  • Top 10 holdings = 74.1% of reported value
  • Largest position: DCTH (DELCATH SYS INC) at 15.4%
  • Average position size: $8.15M

Sector Tilt

  • Health Care 94.7%
  • Industrials 5.3%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 6 new, 7 added, 12 reduced, 8 exited
  • 8 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 83.2%
Materials 0.8%
Other 15.9%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 2.65M $31.91M 16.39%
16.39%
Hold
2 3.00M $19.31M 9.92%
9.92%
Reduce
3 628.05K $11.18M 5.74%
5.74%
Hold
4 3.05M $10.61M 5.45%
5.45%
New
5 3.10M $10.53M 5.41%
5.41%
Hold
6 1.81M $10.06M 5.16%
5.16%
Reduce
7 1.13M $9.64M 4.95%
4.95%
Add
8 870.00K $9.27M 4.76%
4.76%
New
9 2.65M $8.15M 4.18%
4.18%
New
10 1.26M $7.96M 4.09%
4.09%
New
11 810.92K $7.15M 3.67%
3.67%
New
12 150.00K $6.97M 3.58%
3.58%
Reduce
13 2.50M $6.56M 3.37%
3.37%
Reduce
14 877.00K $5.86M 3.01%
3.01%
Reduce
15 692.18K $5.20M 2.67%
2.67%
Add
16 900.00K $4.65M 2.39%
2.39%
New
17 1.06M $4.38M 2.25%
2.25%
Add
18 417.40K $3.65M 1.88%
1.88%
Add
19 260.00K $3.15M 1.62%
1.62%
New
20 1.02M $3.09M 1.59%
1.59%
Add
21 910.70K $2.76M 1.42%
1.42%
New
22 707.62K $2.67M 1.37%
1.37%
Reduce
23 303.86K $2.57M 1.32%
1.32%
Hold
24 252.75K $1.49M 0.76%
0.76%
New
25 417.40K $985.06K 0.51%
0.51%
New
26 183.90K $919.50K 0.47%
0.47%
Reduce
27 811.92K $884.99K 0.45%
0.45%
Add
28 250.56K $826.83K 0.42%
0.42%
Reduce
29 237.50K $807.50K 0.41%
0.41%
New
30 100.00K $356.00K 0.18%
0.18%
Reduce
31 613.94K $321.76K 0.17%
0.17%
Reduce
32 136.60K $300.24K 0.15%
0.15%
New
33 1.28M $281.83K 0.14%
0.14%
New
34 49.44K $220.01K 0.11%
0.11%
Reduce
35 100.00K $52.00K 0.03%
0.03%
New
36 262.50K $480 0.00%
0.00%
New

FAQ

What did Rosalind Advisors, Inc. buy in 2024-Q4?

In its 2024-Q4 13F filing, Rosalind Advisors, Inc. reported 36 equity positions worth $194.74M in aggregate; its largest disclosed positions were DCTH ($31.91M), MYO ($19.31M), MDWD ($11.18M).

How large is Rosalind Advisors, Inc.'s portfolio?

Rosalind Advisors, Inc. reported $194.74M of long equity holdings across 36 positions as of 2024-Q4. Top-10 holdings account for 66.0% of reported value.

What is Rosalind Advisors, Inc.'s investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/rosalind-advisors/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →